Sign up here to receive news updates via email.
-
March 27, 2023 |
Press Releases, News and Updates, Uncategorized
BPGbio Announces Expanded Partnership with debra of America for BPM 31510 for Epidermolysis Bullosa Phase II/III Trial
read moreBPGbio Inc (BPG), an AI-powered biopharma with a mission to reimagine biology for humanity, announced today that the company has reached a partnership agreement with Dystrophic Epidermolysis Bullosa Research Association of America (debra of America) for BPGbio’s BPM 31510 for Epidermolysis Bullosa Phase II/III trial, which is anticipated to launch in the second half of the year. Through the partnership, debra of America will provide support to awareness, understanding, and key information towards patient recruitment and advocacy for the clinical trial.
-
March 6, 2023 |
News and Updates, Press Releases
BPGbio Announces Appointments to its Leadership Team to Accelerate Research and Commercialization
read more -
November 30, 2021 |
Media, Press Releases
AFFPC Celebrates Giving Tuesday By Donating $200,000.00 To BERG’s Project Survival
read moreFunds will support AFFPC’s vision to transform pancreatic cancer treatment through frontline research News provided by BERG Health Nov 30, 2021, 09:00 ET PALM BEACH GARDENS, Fla., Nov. 30, 2021 The Alliance of Families Fighting Pancreatic Cancer (AFFPC) today announced the donation of $200,000.00 to BERG, the clinical stage biotech that employs patient biology and artificial intelligence…
-
November 8, 2021 |
Media, Press Releases
BERG Presents New Research on Potential Therapeutic Path to Fight Huntington’s Disease at The Society for Neuroscience (SfN) Annual Meeting
read moreResults Will Unveil Advancements Aimed to Help Fight this Deadly Disease News provided by BERG Health Nov 08, 2021, 09:00 ET FRAMINGHAM, Mass., Nov. 8, 2021 /PRNewswire/ — BERG, the clinical stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced their participation at…
-
September 16, 2021 |
Media, Press Releases
BERG to Present Latest Research to Improve Pancreatic Treatment at The European Society for Medical Oncology (ESMO) 2021 Congress
read moreResearch will unveil cutting-edge technology to improve the lives of patients suffering from this deadly disease News provided by BERG Health Sep 16, 2021, 09:01 ET FRAMINGHAM, Mass., Sept. 16, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today…
-
July 29, 2021 |
Media, Press Releases
BERG Reveals New Study That Will Seek to Enhance Diagnosis and Treatment of Prostate Cancer
read moreDevelops First AI Blood-Based Biomarker for Disease Diagnosis News provided by BERG Health Jul 29, 2021, 09:30 ET FRAMINGHAM, Mass., July 29, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments and diagnostics, today announced the publication of a new study,…
